Abstract
Only 4.4% of patients with inflammatory carcinomas of the breast survive 5 years. The incidence of the disease is fortunately low at less than 2% of all mammary malignancies, and there is no relationship to pregnancy or lactation. Clinical diagnosis should be supplemented by searches for microscopic metastases in dermal lymphatics and for distant metastases before a therapeutic programme is planned. Combinations of local and systemic treatments best suited to each individual should be devised. The grave outlook justifies the prescription of multimodal regimens incorporating radiotherapy, mastectomy, chemotherapy, immunotherapy, and endocrine therapy from the outset. This may be regarded as providing the best chance of controlling the heterogeneous assortment of cellular types with different therapeutic responsivities within each cancer. Further collaboration between disciplines and centres is essential for the accumulation of expertise in treating this grave disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson J. M., Kelly F., Gettinby G., Wood S. E. Prolonged survival after immunotherapy (irradiated cancer autografts) or mammary cancers, assessed by a measure of therapeutic deficiency. Cancer. 1977 Jul;40(1):30–35. doi: 10.1002/1097-0142(197707)40:1<30::aid-cncr2820400107>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- BYRD B. F., Jr, STEPHENSON S. E., Jr Management of inflammatory breast cancer. South Med J. 1960 Aug;53:945–948. doi: 10.1097/00007611-196008000-00002. [DOI] [PubMed] [Google Scholar]
- Barker J. L., Nelson A. J., Montague E. D. Inflammatory carcinoma of the breast. Radiology. 1976 Oct;121(1):173–176. doi: 10.1148/121.1.173. [DOI] [PubMed] [Google Scholar]
- Droulias C. A., Sewell C. W., Mcsweeney M. B., Powell R. W. Inflammatory carcinoma of the breast: A correlation of clinical, radiologic and pathogic findings. Ann Surg. 1976 Aug;184(2):217–222. doi: 10.1097/00000658-197608000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellis D. L., Teitelbaum S. L. Inflammatory carcinoma of the breast. A pathologic definition. Cancer. 1974 Apr;33(4):1045–1047. doi: 10.1002/1097-0142(197404)33:4<1045::aid-cncr2820330422>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- GUTTMANN R. J. Survival and results after 2-million volt irradiation in the treatment of primary operable carcinoma of the breast with proved positive internal mammary and/or highest axillary nodes. Cancer. 1962 Mar-Apr;15:383–386. doi: 10.1002/1097-0142(196203/04)15:2<383::aid-cncr2820150221>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Lucas F. V., Perez-Mesa C. Inflammatory carcinoma of the breast. Cancer. 1978 Apr;41(4):1595–1605. doi: 10.1002/1097-0142(197804)41:4<1595::aid-cncr2820410450>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- MEYER A. C., DOCKERTY M. B., HARRINGTON S. W. Inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1948 Oct;87(4):417–424. [PubMed] [Google Scholar]
- RICHARDS G. J., Jr, LEWISON E. F. Inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1961 Dec;113:729–732. [PubMed] [Google Scholar]
- ROGERS C. S., FITTS W. T., Jr Inflammatory carcinoma of the breast: a critique of therapy. Surgery. 1956 Feb;39(2):367–370. [PubMed] [Google Scholar]
- Rojas A. F., Feierstein J. N., Mickiewicz E., Glait H., Olivari A. J. Levamisole in advanced human breast cancer. Lancet. 1976 Jan 31;1(7953):211–215. doi: 10.1016/s0140-6736(76)91337-4. [DOI] [PubMed] [Google Scholar]
- TREVES N. The inoperability of inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1959 Aug;109(2):240–242. [PubMed] [Google Scholar]